Keine Kommentare verfügbar.
Founded in 2021, Sinodo Pharmaceutical Technology specializes in peptide product services, integrating R&D, process development and production, with more than 100 employees, over 90% holding bachelor's degrees or higher. Main researchers bring more than 10 years of peptide product development experience and hold multiple intellectual property rights, including 8 authorized patents and 7 invention patents.
Bewertung & Kommentar hinterlassen